{
    "hands_on_practices": [
        {
            "introduction": "This first exercise grounds chronopharmacology in a fundamental principle: the pH-partition hypothesis. You will explore how the well-known circadian rhythm of gastric acid secretion can impact the absorption of a weakly basic drug. By applying the Henderson–Hasselbalch equation, you will quantify how changes in gastric pH between midday and midnight alter the drug's ionization state and, consequently, its predicted absorption rate. ",
            "id": "4933459",
            "problem": "A weakly basic drug exists in equilibrium between its protonated form and its free base according to Brønsted–Lowry acid–base theory. Consider the equilibrium $$\\mathrm{BH}^{+} \\rightleftharpoons \\mathrm{B} + \\mathrm{H}^{+},$$ where the acid dissociation constant is defined by $$K_{a} = \\frac{[\\mathrm{B}][\\mathrm{H}^{+}]}{[\\mathrm{BH}^{+}]},$$ and the negative base-10 logarithm of the acid dissociation constant (denoted as pKa) is $$\\mathrm{p}K_{a} = -\\log_{10}(K_{a}).$$ For a weak base, the fraction of drug in the unionized form is determined by acid–base equilibrium and is related to the luminal hydrogen ion activity (expressed as $\\mathrm{pH}$).\n\nA patient takes an oral dose of a weakly basic drug with $\\mathrm{p}K_{a} = 7.8$. Due to circadian variation in gastric acid secretion, the mean gastric $\\mathrm{pH}$ at midday is $1.8$, while at midnight it is $3.0$. Assume the following scientifically grounded and simplified model:\n- The drug’s absorption across the gastric mucosa is the dominant contribution to its systemic input under these conditions.\n- The first-order absorption rate constant, denoted $k_{a}$, is directly proportional to the fraction of drug that is unionized in the gastric lumen at the time of dosing.\n- All other physiological and formulation factors remain constant between the two dosing times.\n\nUsing the Henderson–Hasselbalch relationship for a weak base and the definition of fraction unionized derived from fundamental acid–base equilibria, compute the predicted ratio $$\\frac{k_{a}(\\text{midnight})}{k_{a}(\\text{midday})}.$$ Express your final result as a pure number (dimensionless) and round your answer to four significant figures.",
            "solution": "The problem is assessed to be valid as it is scientifically grounded in the principles of acid-base chemistry and pharmacokinetics, is well-posed with a clear objective and sufficient information, and uses objective, unambiguous language. The model, while simplified, is a standard and well-established concept (the pH-partition hypothesis) used in pharmaceutical sciences.\n\nThe primary task is to compute the ratio of the first-order absorption rate constants, $k_{a}$, at midnight and midday. The problem states that $k_{a}$ is directly proportional to the fraction of the drug that is in its unionized form, denoted as $f_{u}$. This relationship can be expressed as:\n$$k_{a} = C \\cdot f_{u}$$\nwhere $C$ is a constant of proportionality. Since all other factors are assumed to be constant, $C$ is the same for both dosing times. The desired ratio is therefore:\n$$\\frac{k_{a}(\\text{midnight})}{k_{a}(\\text{midday})} = \\frac{C \\cdot f_{u}(\\text{midnight})}{C \\cdot f_{u}(\\text{midday})} = \\frac{f_{u}(\\text{midnight})}{f_{u}(\\text{midday})}$$\n\nThe next step is to derive an expression for the fraction unionized, $f_{u}$, for a weakly basic drug. The drug exists in an equilibrium between its unionized free base form, $\\mathrm{B}$, and its protonated (ionized) conjugate acid form, $\\mathrm{BH}^{+}$. The equilibrium is:\n$$\\mathrm{BH}^{+} \\rightleftharpoons \\mathrm{B} + \\mathrm{H}^{+}$$\nThe total concentration of the drug, $[\\text{Total}]$, is the sum of the concentrations of the two forms:\n$$[\\text{Total}] = [\\mathrm{B}] + [\\mathrm{BH}^{+}]$$\nThe fraction unionized, $f_{u}$, is the ratio of the concentration of the unionized form to the total drug concentration:\n$$f_{u} = \\frac{[\\mathrm{B}]}{[\\text{Total}]} = \\frac{[\\mathrm{B}]}{[\\mathrm{B}] + [\\mathrm{BH}^{+}]}$$\nTo make this expression more useful, we can divide the numerator and the denominator by $[\\mathrm{B}]$:\n$$f_{u} = \\frac{1}{1 + \\frac{[\\mathrm{BH}^{+}]}{[\\mathrm{B}]}}$$\nThe ratio $\\frac{[\\mathrm{BH}^{+}]}{[\\mathrm{B}]}$ can be determined using the Henderson–Hasselbalch equation. The acid dissociation constant for the conjugate acid $\\mathrm{BH}^{+}$ is given by:\n$$K_{a} = \\frac{[\\mathrm{B}][\\mathrm{H}^{+}]}{[\\mathrm{BH}^{+}]}$$\nTaking the negative base-10 logarithm of both sides gives:\n$$-\\log_{10}(K_{a}) = -\\log_{10}\\left(\\frac{[\\mathrm{B}][\\mathrm{H}^{+}]}{[\\mathrm{BH}^{+}]}\\right)$$\nBy definition, $\\mathrm{p}K_{a} = -\\log_{10}(K_{a})$ and $\\mathrm{pH} = -\\log_{10}([\\mathrm{H}^{+}])$. This yields the Henderson–Hasselbalch equation:\n$$\\mathrm{p}K_{a} = \\mathrm{pH} - \\log_{10}\\left(\\frac{[\\mathrm{B}]}{[\\mathrm{BH}^{+}]}\\right)$$\nRearranging to solve for the logarithm of the ratio:\n$$\\log_{10}\\left(\\frac{[\\mathrm{B}]}{[\\mathrm{BH}^{+}]}\\right) = \\mathrm{pH} - \\mathrm{p}K_{a}$$\nThis implies:\n$$\\frac{[\\mathrm{B}]}{[\\mathrm{BH}^{+}]} = 10^{\\mathrm{pH} - \\mathrm{p}K_{a}}$$\nTaking the reciprocal gives the ratio needed for the $f_{u}$ formula:\n$$\\frac{[\\mathrm{BH}^{+}]}{[\\mathrm{B}]} = 10^{-(\\mathrm{pH} - \\mathrm{p}K_{a})} = 10^{\\mathrm{p}K_{a} - \\mathrm{pH}}$$\nSubstituting this into the expression for $f_{u}$:\n$$f_{u} = \\frac{1}{1 + 10^{\\mathrm{p}K_{a} - \\mathrm{pH}}}$$\nThis is the general formula for the fraction of a weak base in its unionized form at a given $\\mathrm{p}K_{a}$ and $\\mathrm{pH}$.\n\nNow, we can apply this formula using the given values:\n- Drug $\\mathrm{p}K_{a} = 7.8$\n- Gastric $\\mathrm{pH}_{\\text{midday}} = 1.8$\n- Gastric $\\mathrm{pH}_{\\text{midnight}} = 3.0$\n\nFirst, calculate $f_{u}$ at midday:\n$$f_{u}(\\text{midday}) = \\frac{1}{1 + 10^{\\mathrm{p}K_{a} - \\mathrm{pH}_{\\text{midday}}}} = \\frac{1}{1 + 10^{7.8 - 1.8}} = \\frac{1}{1 + 10^{6.0}}$$\nNext, calculate $f_{u}$ at midnight:\n$$f_{u}(\\text{midnight}) = \\frac{1}{1 + 10^{\\mathrm{p}K_{a} - \\mathrm{pH}_{\\text{midnight}}}} = \\frac{1}{1 + 10^{7.8 - 3.0}} = \\frac{1}{1 + 10^{4.8}}$$\nFinally, we compute the ratio:\n$$\\frac{k_{a}(\\text{midnight})}{k_{a}(\\text{midday})} = \\frac{f_{u}(\\text{midnight})}{f_{u}(\\text{midday})} = \\frac{\\frac{1}{1 + 10^{4.8}}}{\\frac{1}{1 + 10^{6.0}}} = \\frac{1 + 10^{6.0}}{1 + 10^{4.8}}$$\nTo find the numerical value:\n$$10^{6.0} = 1,000,000$$\n$$10^{4.8} \\approx 63095.73$$\nThe ratio is:\n$$\\frac{1 + 1,000,000}{1 + 63095.73...} = \\frac{1,000,001}{63096.73...} \\approx 15.8489319$$\nRounding the result to four significant figures as requested gives $15.85$.",
            "answer": "$$\\boxed{15.85}$$"
        },
        {
            "introduction": "Once we recognize that rhythms can influence drug effects, the next step is to quantify them. This practice introduces you to cosinor analysis, the cornerstone technique for characterizing biological rhythms from time-series data. Using a hypothetical dataset for an antihypertensive drug, you will learn how to decompose rhythmic data into its core components: the mean effect (MESOR), the peak-to-trough variation (amplitude), and the timing of the peak (acrophase), providing crucial information for therapeutic assessment. ",
            "id": "4527095",
            "problem": "A patient with stable daily dosing of an antihypertensive agent exhibits a circadian modulation of pharmacodynamic response due to endogenous rhythms. Assume the response over a $24$ hour period can be modeled by a single-component cosinor model with known period, with independent and identically distributed (i.i.d.) Gaussian measurement errors of known variance. Specifically, for time $t$ in hours,\n$$\nE(t) \\;=\\; M \\;+\\; A \\cos\\!\\big(\\omega t + \\phi\\big) \\;+\\; \\varepsilon(t),\n$$\nwhere $E(t)$ is a dimensionless drug-effect index, $M$ is the Midline Estimating Statistic of Rhythm (MESOR), $A$ is the amplitude, $\\phi$ is the acrophase (in radians), $\\omega = \\frac{2\\pi}{24} = \\frac{\\pi}{12}$ is the known angular frequency for a $24$ hour period, and $\\varepsilon(t)$ are i.i.d. errors with $\\varepsilon(t) \\sim \\mathcal{N}(0,\\sigma^{2})$ and known $\\sigma^{2}$. You are given eight evenly spaced observations over a full cycle at times $t_{k} = 3k$ hours for $k = 0,1,\\ldots,7$. The observed effects are:\n- $E(0) = 50 + 10\\sqrt{2}$,\n- $E(3) = 50$,\n- $E(6) = 50 - 10\\sqrt{2}$,\n- $E(9) = 30$,\n- $E(12) = 50 - 10\\sqrt{2}$,\n- $E(15) = 50$,\n- $E(18) = 50 + 10\\sqrt{2}$,\n- $E(21) = 70$.\n\nAssume the assay validation established a known error variance $\\sigma^{2} = 9$. Starting from first principles that define cosinor analysis and the trigonometric angle-addition identity, derive the linear regression representation needed to estimate $M$, $A$, and $\\phi$, obtain their point estimates from the data, and construct approximate $95\\%$ confidence intervals for these parameters using the known $\\sigma^{2}$ and the sampling scheme. Interpret the confidence intervals in the context of chronopharmacology, including the physiological meaning of the acrophase for dosing-time optimization. Finally, report the acrophase $\\phi$ in radians, rounded to four significant figures. Express the acrophase in radians.",
            "solution": "The problem statement is evaluated as scientifically grounded, well-posed, objective, and complete. All necessary data, models, and constants are provided to derive a unique and meaningful solution. The methodology, cosinor analysis via linear regression, is a standard and valid technique in chronopharmacology. The problem is therefore deemed valid.\n\nThe solution proceeds in four stages:\n1.  Linearization of the nonlinear cosinor model into a multiple linear regression form.\n2.  Estimation of the linear model parameters using the method of least squares.\n3.  Transformation of the linear parameter estimates back into the original cosinor parameters ($M$, $A$, $\\phi$).\n4.  Construction and interpretation of approximate $95\\%$ confidence intervals for the cosinor parameters.\n\n**1. Derivation of the Linear Regression Representation**\n\nThe given single-component cosinor model is:\n$$\nE(t) = M + A \\cos(\\omega t + \\phi) + \\varepsilon(t)\n$$\nThis model is nonlinear in the parameters $A$ and $\\phi$. To estimate these parameters using linear regression, we first linearize the model. We use the trigonometric angle-addition identity $\\cos(x+y) = \\cos(x)\\cos(y) - \\sin(x)\\sin(y)$. Applying this to the cosine term gives:\n$$\nA \\cos(\\omega t + \\phi) = A (\\cos(\\omega t)\\cos(\\phi) - \\sin(\\omega t)\\sin(\\phi))\n$$\n$$\nA \\cos(\\omega t + \\phi) = (A\\cos(\\phi))\\cos(\\omega t) + (-A\\sin(\\phi))\\sin(\\omega t)\n$$\nWe define two new parameters, $b_1$ and $b_2$, as:\n$$\nb_1 = A\\cos(\\phi)\n$$\n$$\nb_2 = -A\\sin(\\phi)\n$$\nSubstituting these back into the original model, we obtain a model that is linear in the parameters $M$, $b_1$, and $b_2$:\n$$\nE(t) = M + b_1 \\cos(\\omega t) + b_2 \\sin(\\omega t) + \\varepsilon(t)\n$$\nThis is a multiple linear regression model. For a set of $N$ observations $E(t_k)$ at times $t_k$, the model can be written in matrix form as $Y = X\\beta + \\epsilon$, where:\n$Y = \\begin{pmatrix} E(t_0) \\\\ \\vdots \\\\ E(t_{N-1}) \\end{pmatrix}$, $X = \\begin{pmatrix} 1 & \\cos(\\omega t_0) & \\sin(\\omega t_0) \\\\ \\vdots & \\vdots & \\vdots \\\\ 1 & \\cos(\\omega t_{N-1}) & \\sin(\\omega t_{N-1}) \\end{pmatrix}$, $\\beta = \\begin{pmatrix} M \\\\ b_1 \\\\ b_2 \\end{pmatrix}$, $\\epsilon = \\begin{pmatrix} \\varepsilon(t_0) \\\\ \\vdots \\\\ \\varepsilon(t_{N-1}) \\end{pmatrix}$.\n\n**2. Least Squares Estimation of Linear Parameters**\n\nThe least squares estimate for the parameter vector $\\beta$ is given by $\\hat{\\beta} = (X^T X)^{-1} X^T Y$. The problem specifies $N=8$ observations at times $t_k = 3k$ for $k=0, 1, \\dots, 7$. The angular frequency is $\\omega = \\frac{\\pi}{12}$ rad/hr. Thus, the argument of the trigonometric functions is $\\omega t_k = \\frac{\\pi}{12} (3k) = \\frac{k\\pi}{4}$.\n\nThe design matrix $X$ is populated by columns that are orthogonal due to the symmetric sampling over a full cycle. Let's verify the sums that form the matrix $X^T X$:\n$\\sum_{k=0}^{7} 1 = N = 8$\n$\\sum_{k=0}^{7} \\cos(\\frac{k\\pi}{4}) = 1 + \\frac{\\sqrt{2}}{2} + 0 - \\frac{\\sqrt{2}}{2} - 1 - \\frac{\\sqrt{2}}{2} + 0 + \\frac{\\sqrt{2}}{2} = 0$\n$\\sum_{k=0}^{7} \\sin(\\frac{k\\pi}{4}) = 0 + \\frac{\\sqrt{2}}{2} + 1 + \\frac{\\sqrt{2}}{2} + 0 - \\frac{\\sqrt{2}}{2} - 1 - \\frac{\\sqrt{2}}{2} = 0$\n$\\sum_{k=0}^{7} \\cos(\\frac{k\\pi}{4})\\sin(\\frac{k\\pi}{4}) = \\frac{1}{2}\\sum_{k=0}^{7} \\sin(\\frac{k\\pi}{2}) = \\frac{1}{2}(0+1+0-1+0+1+0-1) = 0$\n$\\sum_{k=0}^{7} \\cos^2(\\frac{k\\pi}{4}) = 1^2 + (\\frac{\\sqrt{2}}{2})^2 + 0^2 + (-\\frac{\\sqrt{2}}{2})^2 + (-1)^2 + (-\\frac{\\sqrt{2}}{2})^2 + 0^2 + (\\frac{\\sqrt{2}}{2})^2 = 1+\\frac{1}{2}+0+\\frac{1}{2}+1+\\frac{1}{2}+0+\\frac{1}{2} = 4 = \\frac{N}{2}$\n$\\sum_{k=0}^{7} \\sin^2(\\frac{k\\pi}{4}) = 0^2 + (\\frac{\\sqrt{2}}{2})^2 + 1^2 + (\\frac{\\sqrt{2}}{2})^2 + 0^2 + (-\\frac{\\sqrt{2}}{2})^2 + (-1)^2 + (-\\frac{\\sqrt{2}}{2})^2 = 0+\\frac{1}{2}+1+\\frac{1}{2}+0+\\frac{1}{2}+1+\\frac{1}{2} = 4 = \\frac{N}{2}$\n\nTherefore, $X^T X$ is a diagonal matrix:\n$$\nX^T X = \\begin{pmatrix} 8 & 0 & 0 \\\\ 0 & 4 & 0 \\\\ 0 & 0 & 4 \\end{pmatrix}\n$$\nIts inverse is simply:\n$$\n(X^T X)^{-1} = \\begin{pmatrix} 1/8 & 0 & 0 \\\\ 0 & 1/4 & 0 \\\\ 0 & 0 & 1/4 \\end{pmatrix}\n$$\nNext, we compute $X^T Y$:\n$\\sum_{k=0}^{7} E(t_k) = (50+10\\sqrt{2}) + 50 + (50-10\\sqrt{2}) + 30 + (50-10\\sqrt{2}) + 50 + (50+10\\sqrt{2}) + 70 = 400$\n$\\sum_{k=0}^{7} E(t_k)\\cos(\\omega t_k) = 1(50+10\\sqrt{2}) + \\frac{\\sqrt{2}}{2}(50) + 0 - \\frac{\\sqrt{2}}{2}(30) - 1(50-10\\sqrt{2}) - \\frac{\\sqrt{2}}{2}(50) + 0 + \\frac{\\sqrt{2}}{2}(70) = 50+10\\sqrt{2} + 25\\sqrt{2} - 15\\sqrt{2} - 50+10\\sqrt{2} - 25\\sqrt{2} + 35\\sqrt{2} = 40\\sqrt{2}$\n$\\sum_{k=0}^{7} E(t_k)\\sin(\\omega t_k) = 0 + \\frac{\\sqrt{2}}{2}(50) + 1(50-10\\sqrt{2}) + \\frac{\\sqrt{2}}{2}(30) + 0 - \\frac{\\sqrt{2}}{2}(50) - 1(50+10\\sqrt{2}) - \\frac{\\sqrt{2}}{2}(70) = 25\\sqrt{2} + 50-10\\sqrt{2} + 15\\sqrt{2} - 25\\sqrt{2} - 50-10\\sqrt{2} - 35\\sqrt{2} = -40\\sqrt{2}$\n\nSo, $X^T Y = \\begin{pmatrix} 400 \\\\ 40\\sqrt{2} \\\\ -40\\sqrt{2} \\end{pmatrix}$.\nThe estimated linear parameter vector is:\n$$\n\\hat{\\beta} = \\begin{pmatrix} \\hat{M} \\\\ \\hat{b}_1 \\\\ \\hat{b}_2 \\end{pmatrix} = (X^T X)^{-1} X^T Y = \\begin{pmatrix} 1/8 & 0 & 0 \\\\ 0 & 1/4 & 0 \\\\ 0 & 0 & 1/4 \\end{pmatrix} \\begin{pmatrix} 400 \\\\ 40\\sqrt{2} \\\\ -40\\sqrt{2} \\end{pmatrix} = \\begin{pmatrix} 50 \\\\ 10\\sqrt{2} \\\\ -10\\sqrt{2} \\end{pmatrix}\n$$\nThus, the point estimates are $\\hat{M}=50$, $\\hat{b}_1=10\\sqrt{2}$, and $\\hat{b}_2=-10\\sqrt{2}$.\n\n**3. Transformation to Cosinor Parameters**\n\nWe now transform $\\hat{b}_1$ and $\\hat{b}_2$ back to estimates for $A$ and $\\phi$. From the definitions $b_1 = A\\cos(\\phi)$ and $b_2 = -A\\sin(\\phi)$:\n$$\nA = \\sqrt{b_1^2 + b_2^2} \\implies \\hat{A} = \\sqrt{\\hat{b}_1^2 + \\hat{b}_2^2} = \\sqrt{(10\\sqrt{2})^2 + (-10\\sqrt{2})^2} = \\sqrt{200 + 200} = \\sqrt{400} = 20\n$$\nFor the acrophase $\\phi$, we have $\\cos(\\phi) = b_1/A$ and $\\sin(\\phi) = -b_2/A$.\n$$\n\\cos(\\hat{\\phi}) = \\frac{\\hat{b}_1}{\\hat{A}} = \\frac{10\\sqrt{2}}{20} = \\frac{\\sqrt{2}}{2}\n$$\n$$\n\\sin(\\hat{\\phi}) = \\frac{-\\hat{b}_2}{\\hat{A}} = \\frac{-(-10\\sqrt{2})}{20} = \\frac{\\sqrt{2}}{2}\n$$\nSince both sine and cosine are positive, $\\hat{\\phi}$ is in the first quadrant.\n$$\n\\hat{\\phi} = \\arccos\\left(\\frac{\\sqrt{2}}{2}\\right) = \\frac{\\pi}{4} \\text{ radians}\n$$\nThe point estimates for the cosinor parameters are $\\hat{M}=50$, $\\hat{A}=20$, and $\\hat{\\phi}=\\pi/4$.\n\n**4. Confidence Intervals and Interpretation**\n\nThe variance of the estimator $\\hat{\\beta}$ is $\\text{Var}(\\hat{\\beta}) = \\sigma^2 (X^T X)^{-1}$, where the error variance $\\sigma^2=9$ is given as known.\n$$\n\\text{Var}(\\hat{\\beta}) = 9 \\begin{pmatrix} 1/8 & 0 & 0 \\\\ 0 & 1/4 & 0 \\\\ 0 & 0 & 1/4 \\end{pmatrix} = \\begin{pmatrix} 9/8 & 0 & 0 \\\\ 0 & 9/4 & 0 \\\\ 0 & 0 & 9/4 \\end{pmatrix}\n$$\nThis gives the variances of the linear parameters: $\\text{Var}(\\hat{M})=9/8$, $\\text{Var}(\\hat{b}_1)=9/4$, and $\\text{Var}(\\hat{b}_2)=9/4$.\nFor a $95\\%$ confidence interval with known variance, we use the z-score $z_{0.025} = 1.96$.\n\n*   **Confidence Interval for M (MESOR):**\n    $$\n    CI_M = \\hat{M} \\pm z_{0.025} \\sqrt{\\text{Var}(\\hat{M})} = 50 \\pm 1.96 \\sqrt{9/8} = 50 \\pm 1.96 \\frac{3}{2\\sqrt{2}} \\approx 50 \\pm 2.079\n    $$\n    $CI_M = [47.92, 52.08]$. We are $95\\%$ confident the true mean drug effect lies in this interval.\n\n*   **Confidence Interval for A (Amplitude):**\n    We use the Delta method for the variance of $\\hat{A} = \\sqrt{\\hat{b}_1^2 + \\hat{b}_2^2}$. Since $\\text{Cov}(\\hat{b}_1, \\hat{b}_2)=0$:\n    $$\n    \\text{Var}(\\hat{A}) \\approx \\left(\\frac{\\partial A}{\\partial b_1}\\right)^2 \\text{Var}(\\hat{b}_1) + \\left(\\frac{\\partial A}{\\partial b_2}\\right)^2 \\text{Var}(\\hat{b}_2) = \\left(\\frac{b_1}{A}\\right)^2 \\text{Var}(\\hat{b}_1) + \\left(\\frac{b_2}{A}\\right)^2 \\text{Var}(\\hat{b}_2)\n    $$\n    Evaluated at the estimates:\n    $$\n    \\text{Var}(\\hat{A}) \\approx \\left(\\frac{10\\sqrt{2}}{20}\\right)^2 \\frac{9}{4} + \\left(\\frac{-10\\sqrt{2}}{20}\\right)^2 \\frac{9}{4} = \\left(\\frac{1}{2}\\right)\\frac{9}{4} + \\left(\\frac{1}{2}\\right)\\frac{9}{4} = \\frac{9}{4}\n    $$\n    $$\n    CI_A = \\hat{A} \\pm z_{0.025} \\sqrt{\\text{Var}(\\hat{A})} = 20 \\pm 1.96 \\sqrt{9/4} = 20 \\pm 1.96(1.5) = 20 \\pm 2.94\n    $$\n    $CI_A = [17.06, 22.94]$. Since this interval does not contain $0$, the circadian rhythm is statistically significant.\n\n*   **Confidence Interval for $\\phi$ (Acrophase):**\n    Using the Delta method for $\\hat{\\phi} = \\arctan(- \\hat{b}_2 / \\hat{b}_1)$:\n    $$\n    \\text{Var}(\\hat{\\phi}) \\approx \\left(\\frac{\\partial \\phi}{\\partial b_1}\\right)^2 \\text{Var}(\\hat{b}_1) + \\left(\\frac{\\partial \\phi}{\\partial b_2}\\right)^2 \\text{Var}(\\hat{b}_2) = \\left(\\frac{b_2}{A^2}\\right)^2 \\text{Var}(\\hat{b}_1) + \\left(\\frac{-b_1}{A^2}\\right)^2 \\text{Var}(\\hat{b}_2)\n    $$\n    $$\n    \\text{Var}(\\hat{\\phi}) \\approx \\frac{1}{A^4} (b_2^2 \\text{Var}(\\hat{b}_1) + b_1^2 \\text{Var}(\\hat{b}_2)) = \\frac{b_1^2+b_2^2}{A^4} \\text{Var}(\\hat{b}_1) = \\frac{A^2}{A^4} \\text{Var}(\\hat{b}_1) = \\frac{\\text{Var}(\\hat{b}_1)}{A^2}\n    $$\n    Evaluated at the estimates:\n    $$\n    \\text{Var}(\\hat{\\phi}) \\approx \\frac{9/4}{20^2} = \\frac{9}{1600}\n    $$\n    $$\n    CI_\\phi = \\hat{\\phi} \\pm z_{0.025} \\sqrt{\\text{Var}(\\hat{\\phi})} = \\frac{\\pi}{4} \\pm 1.96 \\sqrt{\\frac{9}{1600}} = \\frac{\\pi}{4} \\pm 1.96 \\frac{3}{40} = \\frac{\\pi}{4} \\pm 0.147\n    $$\n    $CI_\\phi \\approx 0.7854 \\pm 0.147 = [0.638, 0.932]$ radians.\n\n**Interpretation in Chronopharmacology:**\nThe acrophase, $\\phi$, quantifies the timing of the peak of the circadian rhythm. The peak effect occurs at time $t_{peak}$ when the argument of the cosine is zero: $\\omega t_{peak} + \\phi = 0$.\n$$\nt_{peak} = -\\frac{\\phi}{\\omega} = -\\frac{\\pi/4}{\\pi/12} = -3 \\text{ hours}\n$$\nIn a $24$-hour cycle, this corresponds to $t_{peak} = 21$ hours, or $9$ PM. The minimum effect occurs $\\pi$ radians ($12$ hours) later at $t_{trough} = 9$ hours, or $9$ AM. For an antihypertensive agent, a larger effect index likely means greater blood pressure reduction. This patient's drug regimen results in the strongest effect in the evening and the weakest effect in the morning.\nThis information is critical for dosing-time optimization. Many hypertensive patients experience a \"morning surge\" in blood pressure, a period of high cardiovascular risk. The finding that the drug's effect is at its nadir at $9$ AM suggests the current dosing schedule may be suboptimal for controlling this surge. A clinician might use this acrophase information to recommend shifting the dosing time (e.g., to the evening) to better align the peak drug effect with the time of greatest physiological need, thereby improving therapeutic outcomes. The confidence interval for $\\phi$ quantifies the statistical certainty of this timing.\n\nThe final requested value is the acrophase $\\phi$ in radians, rounded to four significant figures.\n$\\hat{\\phi} = \\frac{\\pi}{4} \\approx 0.785398...$\nRounded to four significant figures, this is $0.7854$.",
            "answer": "$$\\boxed{0.7854}$$"
        },
        {
            "introduction": "This final practice integrates the principles of pharmacokinetics and circadian rhythms to solve a real-world optimization problem. You will model the interaction between a short-acting statin and the nocturnal rhythm of its target enzyme, HMG-CoA reductase, to determine the ideal dosing time. This exercise demonstrates the ultimate goal of chronopharmacology: to build predictive models that guide dosing strategies to maximize therapeutic efficacy by aligning drug exposure with windows of biological opportunity. ",
            "id": "4933375",
            "problem": "A short-acting statin is used to inhibit 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase, whose hepatic activity exhibits a circadian rhythm with a single daily peak during the night. For an advanced pharmacology analysis of chronopharmacology and circadian dosing, consider the following scientifically grounded model.\n\nHepatic HMG-CoA reductase activity is modeled as a cosine function of time $t$ (in hours) over a $24$-hour period:\n$$A(t) = A_{0} + A_{1}\\cos\\!\\big(\\omega\\,(t - t_{p})\\big),$$\nwhere $A_{0} > 0$ and $A_{1} > 0$ are constants, the angular frequency is $\\omega = \\frac{2\\pi}{24}$ radians per hour, and the peak time is $t_{p} = 2.0$ hours (corresponding to 02:00 local time). Assume the cosine argument is measured in radians.\n\nA single immediate-release oral dose of the statin is administered once daily at a fixed time $t_{d}$ (in hours on a $24$-hour clock, with $0$ corresponding to 00:00). Absorption is assumed to be effectively instantaneous into the central compartment, distribution is rapid, and elimination follows first-order kinetics. Thus, after a dose at time $t_{d}$, the central concentration for $t \\ge t_{d}$ is\n$$C(t) = C_{\\max}\\,\\exp\\!\\big(-k_{e}(t - t_{d})\\big),$$\nand $C(t) = 0$ for $t < t_{d}$. The elimination rate constant $k_{e}$ is related to the elimination half-life $t_{1/2}$ by $k_{e} = \\frac{\\ln 2}{t_{1/2}}$. For this statin, take $t_{1/2} = 2.0$ hours.\n\nAssume that, for one dosing interval, the net inhibitory drive relevant to low-density lipoprotein cholesterol synthesis is proportional to the time integral of the product $A(t)\\,C(t)$ over the post-dose period (you may treat the upper limit as effectively infinite because the concentration decays exponentially and $t_{1/2}$ is short compared to $24$ hours). Using only fundamental pharmacokinetic definitions and standard properties of integrals and trigonometric functions, determine the dosing time $t_{d}$ that maximizes the integral\n$$E(t_{d}) \\propto \\int_{t_{d}}^{\\infty} A(t)\\,C(t)\\,dt.$$\n\nExpress the optimal dosing time $t_{d}$ as a clock time in hours on the $0$ to $24$ scale, reduced modulo $24$ so it lies in $[0,24)$, and round your answer to four significant figures. Use radians for any angles and express the final clock time in hours (do not convert to minutes).",
            "solution": "The problem requires finding the optimal dosing time, $t_d$, that maximizes the net inhibitory drive, $E(t_d)$. The inhibitory drive is given as being proportional to the time integral of the product of the enzyme activity, $A(t)$, and the drug concentration, $C(t)$, over the post-dose period.\n$$E(t_{d}) \\propto \\int_{t_{d}}^{\\infty} A(t)\\,C(t)\\,dt$$\nMaximizing $E(t_{d})$ is equivalent to maximizing the integral itself. Let's define an objective function $I(t_d)$ which we aim to maximize, dropping any positive proportionality constants that do not affect the location of the maximum.\n\nThe given functions are:\n$$A(t) = A_{0} + A_{1}\\cos\\!\\big(\\omega\\,(t - t_{p})\\big)$$\n$$C(t) = C_{\\max}\\,\\exp\\!\\big(-k_{e}(t - t_{d})\\big) \\quad \\text{for } t \\ge t_{d}$$\nThe integral to maximize is:\n$$I(t_d) = \\int_{t_{d}}^{\\infty} \\Big(A_{0} + A_{1}\\cos\\big(\\omega(t - t_p)\\big)\\Big) \\Big(C_{\\max}\\,\\exp\\big(-k_{e}(t - t_{d})\\big)\\Big) \\,dt$$\nSince $C_{\\max}$ is a positive constant, we can remove it from the expression we are maximizing. Let $J(t_d) = I(t_d) / C_{\\max}$.\n$$J(t_d) = \\int_{t_{d}}^{\\infty} \\Big(A_{0} + A_{1}\\cos\\big(\\omega(t - t_p)\\big)\\Big) \\exp\\big(-k_{e}(t - t_{d})\\big) \\,dt$$\nTo simplify this integral, we perform a change of variables. Let $u = t - t_{d}$. This implies $t = u + t_{d}$ and $dt = du$. The limits of integration become $u = t_{d} - t_{d} = 0$ and $u \\to \\infty$ as $t \\to \\infty$.\n$$J(t_d) = \\int_{0}^{\\infty} \\Big(A_{0} + A_{1}\\cos\\big(\\omega(u + t_d - t_p)\\big)\\Big) \\exp(-k_{e}u) \\,du$$\nWe can split the integral into two parts:\n$$J(t_d) = \\int_{0}^{\\infty} A_{0}\\exp(-k_{e}u) \\,du + \\int_{0}^{\\infty} A_{1}\\cos\\big(\\omega(u + t_d - t_p)\\big) \\exp(-k_{e}u) \\,du$$\nThe first integral is:\n$$A_{0}\\int_{0}^{\\infty} \\exp(-k_{e}u) \\,du = A_{0} \\left[ -\\frac{1}{k_e} \\exp(-k_{e}u) \\right]_{0}^{\\infty} = A_{0} \\left( 0 - \\left(-\\frac{1}{k_e}\\right) \\right) = \\frac{A_{0}}{k_e}$$\nThis term is a constant with respect to $t_d$ and thus does not influence the location of the maximum. We only need to maximize the second term, which we call $J_{var}(t_d)$.\n$$J_{var}(t_d) = A_{1} \\int_{0}^{\\infty} \\cos\\big(\\omega(u + t_d - t_p)\\big) \\exp(-k_{e}u) \\,du$$\nLet's use the cosine angle addition formula, $\\cos(X+Y) = \\cos(X)\\cos(Y) - \\sin(X)\\sin(Y)$. Let $X = \\omega u$ and $Y = \\omega(t_d - t_p)$.\n$$\\cos\\big(\\omega u + \\omega(t_d - t_p)\\big) = \\cos(\\omega u)\\cos\\big(\\omega(t_d - t_p)\\big) - \\sin(\\omega u)\\sin\\big(\\omega(t_d - t_p)\\big)$$\nSubstituting this into the integral for $J_{var}(t_d)$:\n$$J_{var}(t_d) = A_{1} \\left[ \\cos\\big(\\omega(t_d - t_p)\\big) \\int_{0}^{\\infty} \\cos(\\omega u) \\exp(-k_{e}u) \\,du - \\sin\\big(\\omega(t_d - t_p)\\big) \\int_{0}^{\\infty} \\sin(\\omega u) \\exp(-k_{e}u) \\,du \\right]$$\nThese integrals are standard Laplace transforms of cosine and sine functions.\n$$\\mathcal{L}\\{\\cos(at)\\}(s) = \\int_0^\\infty \\exp(-st)\\cos(at)\\,dt = \\frac{s}{s^2+a^2}$$\n$$\\mathcal{L}\\{\\sin(at)\\}(s) = \\int_0^\\infty \\exp(-st)\\sin(at)\\,dt = \\frac{a}{s^2+a^2}$$\nIn our case, the variable is $u$, the Laplace variable $s$ is $k_e$, and the frequency $a$ is $\\omega$. Therefore:\n$$\\int_{0}^{\\infty} \\cos(\\omega u) \\exp(-k_{e}u) \\,du = \\frac{k_e}{k_e^2 + \\omega^2}$$\n$$\\int_{0}^{\\infty} \\sin(\\omega u) \\exp(-k_{e}u) \\,du = \\frac{\\omega}{k_e^2 + \\omega^2}$$\nSubstituting these results back into the expression for $J_{var}(t_d)$:\n$$J_{var}(t_d) = A_{1} \\left[ \\cos\\big(\\omega(t_d - t_p)\\big) \\frac{k_e}{k_e^2 + \\omega^2} - \\sin\\big(\\omega(t_d - t_p)\\big) \\frac{\\omega}{k_e^2 + \\omega^2} \\right]$$\n$$J_{var}(t_d) = \\frac{A_{1}}{k_e^2 + \\omega^2} \\Big( k_e \\cos\\big(\\omega(t_d - t_p)\\big) - \\omega \\sin\\big(\\omega(t_d - t_p)\\big) \\Big)$$\nTo maximize this expression, we use the harmonic addition theorem. An expression of the form $a\\cos\\theta - b\\sin\\theta$ can be written as $R\\cos(\\theta + \\alpha)$, where $R = \\sqrt{a^2+b^2}$ and $\\alpha = \\arctan(b/a)$. Here, $a=k_e$, $b=\\omega$, and $\\theta = \\omega(t_d - t_p)$.\nThe expression becomes $R\\cos(\\omega(t_d-t_p) + \\alpha)$, where $R = \\sqrt{k_e^2 + \\omega^2}$ and $\\alpha = \\arctan(\\omega/k_e)$.\nSince $A_1 > 0$ and $k_e^2 + \\omega^2 > 0$, maximizing $J_{var}(t_d)$ is equivalent to maximizing $\\cos(\\omega(t_d - t_p) + \\alpha)$.\nThe maximum value of the cosine function is $1$, which occurs when its argument is an integer multiple of $2\\pi$.\n$$\\omega(t_d - t_p) + \\alpha = 2n\\pi, \\quad n \\in \\mathbb{Z}$$\nSolving for $t_d$:\n$$\\omega(t_d - t_p) = -\\alpha + 2n\\pi$$\n$$t_d - t_p = -\\frac{\\alpha}{\\omega} + \\frac{2n\\pi}{\\omega}$$\n$$t_d = t_p - \\frac{\\alpha}{\\omega} + \\frac{2n\\pi}{\\omega}$$\nSubstituting $\\alpha = \\arctan(\\omega/k_e)$ and noting that the period of the rhythm is $T = 2\\pi/\\omega = 24$ hours:\n$$t_d = t_p - \\frac{1}{\\omega} \\arctan\\left(\\frac{\\omega}{k_e}\\right) + n \\cdot 24$$\nWe need to find the unique solution for $t_d$ in the interval $[0, 24)$.\n\nThe given parameters are:\n$t_p = 2.0$ hours.\n$t_{1/2} = 2.0$ hours.\n$\\omega = \\frac{2\\pi}{24} = \\frac{\\pi}{12}$ rad/hr.\nThe elimination rate constant $k_e$ is related to the half-life $t_{1/2}$ by:\n$$k_e = \\frac{\\ln 2}{t_{1/2}} = \\frac{\\ln 2}{2.0} \\text{ hr}^{-1}$$\nNow we compute the ratio $\\omega/k_e$:\n$$\\frac{\\omega}{k_e} = \\frac{\\pi/12}{(\\ln 2)/2} = \\frac{\\pi}{12} \\cdot \\frac{2}{\\ln 2} = \\frac{\\pi}{6 \\ln 2}$$\nThe argument of the arctangent function must be in radians, which it is. Let's calculate the numerical value of the time shift term:\n$$\\frac{1}{\\omega} \\arctan\\left(\\frac{\\omega}{k_e}\\right) = \\frac{12}{\\pi} \\arctan\\left(\\frac{\\pi}{6 \\ln 2}\\right)$$\nUsing standard values $\\pi \\approx 3.14159265$ and $\\ln 2 \\approx 0.69314718$:\n$$\\frac{\\pi}{6 \\ln 2} \\approx \\frac{3.14159265}{6 \\times 0.69314718} \\approx \\frac{3.14159265}{4.15888308} \\approx 0.755393$$\nThe angle $\\alpha$ is:\n$$\\alpha = \\arctan(0.755393) \\approx 0.647078 \\text{ radians}$$\nThe time shift is:\n$$\\frac{\\alpha}{\\omega} = \\frac{0.647078}{\\pi/12} \\approx \\frac{0.647078}{0.261799} \\approx 2.47160 \\text{ hours}$$\nNow we can compute $t_d$:\n$$t_d = t_p - 2.47160 + n \\cdot 24$$\n$$t_d = 2.0 - 2.47160 + n \\cdot 24 = -0.47160 + n \\cdot 24$$\nTo bring $t_d$ into the interval $[0, 24)$, we choose $n=1$:\n$$t_d = -0.47160 + 24 = 23.52840$$\nThe problem asks to round the answer to four significant figures.\n$$t_d \\approx 23.53 \\text{ hours}$$\nThis corresponds to a clock time of approximately $23:32$. Dosing in the late evening is consistent with clinical recommendations for short-acting statins to counteract the nocturnal peak of cholesterol synthesis.",
            "answer": "$$\\boxed{23.53}$$"
        }
    ]
}